Company Description
Novo Nordisk can tell diabetics where to stick it. One of the world's leading producers of insulin, Novo Nordisk also makes insulin analogues,...
Key Novo Nordisk Financials
| Company Type | Public - NYSE: NVO; Copenhagen: NOVO B Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $8,261.6 |
| 2007 Employees | 26,000 |
More Novo Nordisk Financials (11 pages)
Rankings
- #229 in FT Global 500
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Novo Nordisk's competition across multiple industries
Top Novo Nordisk Competitors
Sponsored Links
The Business Directory
Novo Nordisk Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Sten Scheibye | Network | E-mail |
| President and CEO | Lars Rebien Sørensen | Network | E-mail |
| EVP and CFO | Jesper Brandgaard | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Novo Nordisk News
- Analyst Actions: Novo-Nordisk Down 2% After Downgrade [Midnight Trader] (29 Aug 2008 09:17:00 EDT)
- BioWorld Today August 28, 2008 [BioWorld Today] (28 Aug 2008 00:01:00 EDT)
- Companies report 4 new deaths with diabetes drug [AP Financial News] (26 Aug 2008 22:11:00 EDT)
Sponsored Opportunity
